Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.
about
Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.6β-N-heterocyclic substituted naltrexamine derivative NAP as a potential lead to develop peripheral mu opioid receptor selective antagonists.Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased FashionSynthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer.Nanoconjugated NAP as a Potent and Periphery Selective Mu Opioid Receptor Modulator To Treat Opioid-Induced Constipation.Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception.
P2860
Q33815047-EE882908-C7EA-4253-9D77-2D5BD69C7005Q36090988-CB99B003-DB19-41D8-B623-952D2E54CF14Q36480105-06BA760E-BE63-41F7-848C-B0CAB43B61F5Q37417284-D263DBE8-7D07-4905-995B-A86E10DEC546Q38909015-F196C727-A324-4F83-9A9B-0C90DBD0AC80Q44342749-3BE30C05-59DB-41F7-8A08-97B9EE003165Q47147106-ABF74594-2A81-4E31-A356-A8BFEABA5D19
P2860
Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.
@ast
Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.
@en
type
label
Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.
@ast
Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.
@en
prefLabel
Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.
@ast
Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.
@en
P2093
P2860
P356
P1476
Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.
@en
P2093
Jürgen Venitz
Pallabi Mitra
Phillip M Gerk
Yunyun Yuan
P2860
P304
P356
10.1124/DMD.111.038588
P577
2011-06-17T00:00:00Z